Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Titlesort descending Type $ Amount Activity Investigator Unit Sponsor Date
Contract $231,030.00 Clinical Trial Steve Chung COM Phx Neurology NCGS Incorporated 03/2020
(00007885) A Randomized, Double-Blind, Placebo-Controlled Study of 4-Hydroxytamoxifen Topic Gel Among Women with Mammograpically Dense Breast - (Fixed Price) Contract $78,600.00 Clinical Trial Pavani Chalasani Cancer Center Division University of Texas: MD Anderson Cancer Center 03/2020
2020 ASH Hematology Opportunities for the Next-Generation of Research Scientists (HONORS) Award Grant $5,000.00 Research Jasmine Smith Pediatrics American Society of Hematology 07/2020
5-HT1F Receptor Mediated Mitochondrial Biogenesis for The Treatment of Spinal Cord Injury Fellowship $112,449.00 Research Training Epiphani Simmons Pharmacology and Toxicology National Institute of Neurological Disorders and Stroke 08/2020
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 with Placebo and with Tofacitinib in Combination with Conventional Synthetic DMARDs.... Contract $314,050.00 Clinical Trial Chian Kwoh Arthritis Center-Research IQVIA RDS Inc. 03/2020
A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American men Grant $666,360.00 Research training David Garcia Health Promotion Sciences National Institute on Minority Health and Health Disparities 02/2020
A Genetically Engineered Human Fetal Liver Niche as a Novel Platform for Biomanufacturing of Hematopoietic Stem Cells Grant $248,129.00 Research David Harris UAHS Research University of Pittsburgh 07/2020
A Mixed Method to Identify Causes of Kidney Cancer Surgical Disparities in Arizona Grant $388,482.00 Research Ken Batai Surgery National Cancer Institute 06/2020
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome (ARDS.. Contract $168,927.92 Clinical Trial Marilyn Glassberg Csete COM Phx Internal Medicine Kinevant Sciences, Inc. 08/2020
A Multicenter, Double-Blind, Multidose, Placebo-Controlled, Randomized, Parallel-Group, Phase 2 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 for Patients with Brain Contusion Contract $96,267.00 Clinical Trial Bellal Joseph Surgery Biogen Incorporated 03/2020
A Novel Approach to Help Women of Reproductive Age Quit Smoking Grant $100,000.00 Research Alicia Allen Family and Community Medicine Prevent Cancer Foundation 04/2020
A Phase 1 Open-Label, Multicenter Study to Evaluate Biomarkers for ZN-c5 in Subjects with Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Contract $91,617.50 Clinical Trial Pavani Chalasani Cancer Center Division Zeno Pharmaceuticals, Inc. 01/2020
A Phase 1 Study of ERK1/2 Inhibitor JSI-1187 Administered as Monotherapy and in Combination with Dabrafenib for the Treatment of Advanced Solid Tumors with MAPK Pathway Mutations Contract $643,931.75 Clinical Trial Hani Babiker Cancer Center Division Strategia Therapeutics 06/2020
A Phase 1, Open-label Study of ASP9801, an Oncolytic Virus, Administered by Intratumoral Injection in Patients with Advanced/Metastatic Solid Tumors Contract $458,027.74 Clinical Trial Hani Babiker Cancer Center Division Parexel International Corporation 01/2020
A Phase 1/2 Study of ZN-c3 as a Single Agent in Combination with Talazoparib or Pembrolizumab in Patients with Solid Tumors Contract $138,409.52 Clinical Trial Pavani Chalasani Cancer Center Division K-Group Beta, Inc. 03/2020
A Phase 1b/2 Study of AST-008 Combined with Pembrolizumab or Cemiplimab in Patients with Advanced Solid Tumors Contract $157,802.00 Clinical Trial Montaser Shaheen Cancer Center Division Exicure, Inc. 06/2020
A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal And Genitourinary Tumors Contract $682,977.50 Clinical Trial Edward Gelmann Cancer Center Division Pharmacyclics Incorporated 04/2020
A Phase 2 Open-Label Study of Brentuximab Vedotin in Front-Line Therapy of Hodgkin Lymphoma (HL) and CD30-Expressing Peripheral T-cell Lymphoma (PTCL) in Adults Age 60 and Above Contract $147,691.00 Clinical Trial Daniel Persky Cancer Center Division Seattle Genetics, Incorporated 05/2020
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients with Diffuse Cutaneous Systemic Sclerosis or Systemic Sclerosis-Associated... Contract $55,928.00 Clinical Trial Chian Kwoh Arthritis Center-Research Cumberland Pharmaceuticals, Incorporated 07/2020
A Phase 2, Double-Blind, Placebo-Controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Relationships of Different Doses.... Contract $273,767.50 Clinical Trial Cori Daines Asthma/Airway Disease Rsch Ctr Janssen Research & Development, LLC 01/2020
A Phase 2, Multi-Center, Open-Label Study to Evaluate Long-term Safety and Efficacy of CXA-10 in Subjects with Pulmonary Arterial Hypertension on Stable Background Therapy: Extension to Study CXA-10-3 Contract $80,418.76 Clinical Trial Franz Rischard Medicine Complexa, Inc. 01/2020
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants with Previously Treated Locally Advanced/Metastatic or Surgically Unresectable.. Contract $171,440.00 Clinical Trial Aaron Scott Cancer Center Division Incyte Corporation 05/2020
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of VX-814 in PiZZ Subjects Contract $79,672.00 Clinical Trial Ramachandra Sista COM Phx Internal Medicine Vertex Pharmaceuticals, Incorporated 05/2020
A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11;14)-Positive Relapsed or Refractory Multiple... Contract $392,700.50 Clinical Trial Krisstina Gowin Cancer Center Division AbbVie Incorporated 07/2020
A Phase 3, Randomized, Double- Blinded, Placebo-Controlled Trial To Evaluate the Efficacy and Safety of a Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Infants Born to.... Contract $124,499.00 Clinical Trial Mohamed Ahmed Pediatrics Pfizer, Incorporated 05/2020

Pages